ROMAGNOLI, Dante
 Distribuzione geografica
Continente #
NA - Nord America 4.392
AS - Asia 2.016
EU - Europa 1.984
SA - Sud America 278
AF - Africa 59
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.764
Nazione #
US - Stati Uniti d'America 4.335
SG - Singapore 673
CN - Cina 540
GB - Regno Unito 429
IT - Italia 311
PL - Polonia 241
HK - Hong Kong 224
DE - Germania 212
VN - Vietnam 209
BR - Brasile 203
FI - Finlandia 195
SE - Svezia 166
RU - Federazione Russa 101
FR - Francia 97
UA - Ucraina 64
IN - India 51
TR - Turchia 51
ID - Indonesia 44
BD - Bangladesh 40
KR - Corea 39
BG - Bulgaria 30
JP - Giappone 30
AR - Argentina 29
CA - Canada 29
AU - Australia 27
LT - Lituania 27
NL - Olanda 22
IQ - Iraq 18
MX - Messico 17
EG - Egitto 15
ZA - Sudafrica 15
EC - Ecuador 12
AT - Austria 11
ES - Italia 11
PK - Pakistan 11
BE - Belgio 10
GR - Grecia 10
IE - Irlanda 9
SA - Arabia Saudita 9
MA - Marocco 8
MY - Malesia 8
PH - Filippine 8
SI - Slovenia 8
CO - Colombia 7
JO - Giordania 7
PE - Perù 7
CZ - Repubblica Ceca 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BH - Bahrain 5
DZ - Algeria 5
EU - Europa 5
UY - Uruguay 5
VE - Venezuela 5
CH - Svizzera 4
CL - Cile 4
NP - Nepal 4
TH - Thailandia 4
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
ET - Etiopia 3
IR - Iran 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PY - Paraguay 3
SV - El Salvador 3
TW - Taiwan 3
CI - Costa d'Avorio 2
GE - Georgia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MN - Mongolia 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TN - Tunisia 2
UG - Uganda 2
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
Totale 8.757
Città #
Fairfield 505
Singapore 473
Ashburn 450
Santa Clara 388
Woodbridge 295
Chandler 253
Seattle 246
Southend 246
Houston 242
Warsaw 238
Hong Kong 216
Wilmington 187
Helsinki 182
Cambridge 154
San Jose 142
Nyköping 125
Dearborn 123
Hefei 108
Ann Arbor 99
Council Bluffs 94
London 87
Modena 86
Beijing 85
Jacksonville 77
New York 75
Ho Chi Minh City 63
Hanoi 58
Los Angeles 54
The Dalles 52
Chicago 43
Shanghai 39
Lauterbourg 38
Seoul 37
San Diego 34
Izmir 32
Jakarta 28
Sofia 28
Moscow 27
Princeton 26
Eugene 25
Munich 23
Guangzhou 20
Frankfurt am Main 19
Melbourne 19
Salt Lake City 18
São Paulo 18
Buffalo 17
Milan 17
Tokyo 16
Denver 14
Redwood City 14
Dallas 12
Orem 12
Redondo Beach 12
Rome 12
Da Nang 11
Athens 10
Boardman 10
Bologna 10
Dong Ket 10
Fremont 10
Manchester 10
Phoenix 10
Stockholm 10
Amsterdam 9
Bremen 9
Brussels 9
Chennai 9
Dublin 9
Johannesburg 9
San Mateo 9
Schiffdorf 9
Haiphong 8
Padova 8
Palisades Park 8
Boston 7
Carpi 7
Nanjing 7
Semarang 7
Toronto 7
Amman 6
Atlanta 6
Brno 6
Dhaka 6
Florence 6
Kent 6
Mexico City 6
Montreal 6
Paris 6
Portsmouth 6
Rio de Janeiro 6
Shibīn al Kawm 6
Vienna 6
Columbus 5
Curitiba 5
Gifu 5
Grafing 5
Guayaquil 5
Lima 5
Mumbai 5
Totale 6.338
Nome #
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 474
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 439
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 371
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 364
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 349
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 345
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 327
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 325
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 322
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 311
Nonalcoholic fatty liver disease and aging: epidemiology to management 311
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 295
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 287
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 275
Alcohol and Steatosis: The Japanese Paradox 268
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 264
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 260
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 258
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in Italy 256
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy 247
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 232
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 219
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 205
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 201
Gender differences in chronic alcoholic and viral liver diseases 196
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 195
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 195
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 186
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 177
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 162
Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target 159
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy 157
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 152
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 32
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 22
Totale 8.838
Categoria #
all - tutte 33.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 0 0 0 0 96 96 54
2021/2022523 46 51 19 20 14 37 25 28 68 46 119 50
2022/2023691 68 90 61 77 67 77 15 74 75 9 35 43
2023/2024465 23 33 57 33 71 47 19 36 19 7 52 68
2024/20251.486 30 13 39 105 303 215 108 98 160 66 163 186
2025/20262.950 206 131 210 285 404 501 426 150 353 284 0 0
Totale 8.838